Join
Zimmer Biomet Holdings Inc. logo

ZBH

NYSE

Zimmer Biomet Holdings Inc.

SectorHealth CareIndustryIndustrial Specialties
$85.02+1.24 (+1.48%)
News25/Ratings12

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Price$85.02+0.24 (+0.28%)
01:30 PM07:45 PM
News · 26 weeks95+157%
2025-12-07: 02025-12-14: 32025-12-21: 12025-12-28: 02026-01-04: 102026-01-11: 22026-01-18: 02026-01-25: 02026-02-01: 02026-02-08: 22026-02-15: 32026-02-22: 252026-03-01: 02026-03-08: 82026-03-15: 12026-03-22: 22026-03-29: 112026-04-05: 22026-04-12: 02026-04-19: 02026-04-26: 52026-05-03: 22026-05-10: 32026-05-17: 12026-05-24: 112026-05-31: 3
2025-12-072026-05-31
Mix4990d
  • Insider29(59%)
  • SEC Filings8(16%)
  • Other8(16%)
  • Earnings2(4%)
  • Analyst1(2%)
  • Leadership1(2%)

Latest news

25 items

ZBH FAQ

7 questions
  • What does Zimmer Biomet Holdings Inc. do?
    Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the...
  • Where does ZBH stock trade?
    Zimmer Biomet Holdings Inc. (ZBH) is listed on NYSE.
  • What sector and industry is ZBH in?
    Zimmer Biomet Holdings Inc. operates in the Health Care sector, Industrial Specialties industry.
  • Does ZBH pay a dividend?
    Yes. ZBH's next ex-dividend date is 2026-06-25 with a declared cash dividend of $0.24 per share, payable 2026-07-31.
  • What are analysts saying about ZBH?
    Zimmer Biomet Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from BTIG Research: Neutral on 2026-03-23.
  • What companies are similar to ZBH?
    Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), MAS (Masco Corporation), SNN (Smith & Nephew SNATS Inc.). Compare ZBH side-by-side with any of them on Quantisnow.
  • How can I track ZBH on Quantisnow?
    Quantisnow aggregates Zimmer Biomet Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ZBH to receive live email and push alerts on every new disclosure.